These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Is a cataract avoidable? Current status with special emphasis on the pathophysiology of oxidative lens damage, nutritional factors, and the ARED study]. Kottler UB; Dick HB; Augustin AJ Ophthalmologe; 2003 Mar; 100(3):190-6. PubMed ID: 12640547 [TBL] [Abstract][Full Text] [Related]
5. [Risk factors in cataract]. Vîrgolici B; Popescu L Oftalmologia; 2006; 50(2):3-9. PubMed ID: 16927750 [TBL] [Abstract][Full Text] [Related]
6. [Prevention of various types of cataract by using non-steroidal anti-inflammatory drugs]. Kotowska I; Gumułka W Pol Tyg Lek; 1987 Dec 21-28; 42(51-52):1660-1. PubMed ID: 3452813 [No Abstract] [Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
8. Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability. Brune K Curr Med Res Opin; 2007 Dec; 23(12):2985-95. PubMed ID: 17949535 [TBL] [Abstract][Full Text] [Related]
9. Effect of curcumin on galactose-induced cataractogenesis in rats. Suryanarayana P; Krishnaswamy K; Reddy GB Mol Vis; 2003 Jun; 9():223-30. PubMed ID: 12802258 [TBL] [Abstract][Full Text] [Related]
10. Advances in pharmacological strategies for the prevention of cataract development. Gupta SK; Selvan VK; Agrawal SS; Saxena R Indian J Ophthalmol; 2009; 57(3):175-83. PubMed ID: 19384010 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Suryanarayana P; Kumar PA; Saraswat M; Petrash JM; Reddy GB Mol Vis; 2004 Mar; 10():148-54. PubMed ID: 15031705 [TBL] [Abstract][Full Text] [Related]
12. [Radiation protectants of the crystalline lens]. Belkacémi Y; Pasquier D; Castelain B; Warnet JM; Lartigau E Cancer Radiother; 2003 Nov; 7 Suppl 1():49s-54s. PubMed ID: 15124544 [TBL] [Abstract][Full Text] [Related]
13. Photodynamics of cataract: an update on endogenous chromophores and antioxidants. Balasubramanian D Photochem Photobiol; 2005; 81(3):498-501. PubMed ID: 15623354 [TBL] [Abstract][Full Text] [Related]
14. Relationship between aldose reductase inhibiting activity and anti-cataract action of various non-steroidal anti-inflammatory drugs. Gupta SK; Joshi S Dev Ophthalmol; 1991; 21():151-6. PubMed ID: 1907930 [No Abstract] [Full Text] [Related]
16. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Chan FK; Graham DY Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194 [TBL] [Abstract][Full Text] [Related]
18. External factors in the development of cataract. Robman L; Taylor H Eye (Lond); 2005 Oct; 19(10):1074-82. PubMed ID: 16304587 [TBL] [Abstract][Full Text] [Related]
19. Effect of Diabecon on sugar-induced lens opacity in organ culture: mechanism of action. Moghaddam MS; Kumar PA; Reddy GB; Ghole VS J Ethnopharmacol; 2005 Feb; 97(2):397-403. PubMed ID: 15707781 [TBL] [Abstract][Full Text] [Related]
20. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats. Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]